UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

Annals of oncology, 2017-02, Vol.28 (2), p.270-277

2017

Volltextzugriff (PDF)

Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials

Annals of oncology, 2016-11, Vol.27 (11), p.2103-2110

2016

Volltextzugriff (PDF)

Nanofatigue behaviour of single struts of cast A356.0 foam: cyclic deformation, nanoindent characteristics and sub-surface microstructure

Materials & design, 2020-10, Vol.195, p.109016, Article 109016

2020

Volltextzugriff (PDF)

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104

British journal of cancer, 2013-02, Vol.108 (2), p.469-476

2013

Volltextzugriff (PDF)

Afatinib followed by osimertinib in patients with EGFR mutation-positive advanced NSCLC: A real-world study (GioTag)

Annals of oncology, 2018-11, Vol.29, p.ix176-ix177

2018

Volltextzugriff (PDF)

Oxidative Stress Leads to β-Cell Dysfunction Through Loss of β-Cell Identity

Frontiers in immunology, 2021-11, Vol.12, p.690379-690379

2021

Volltextzugriff (PDF)

Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages

Cell reports (Cambridge), 2016-10, Vol.17 (3), p.684-696

2016

Volltextzugriff (PDF)

Intratumoural injection of the toll-like receptor-2 6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I II trial

British journal of cancer, 2007-08, Vol.97 (5), p.598-604

2007

Volltextzugriff (PDF)

Afatinib vs gefitinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: overall survival (OS) data from LUX-Lung 7 (LL7)

European journal of cancer (1990), 2017-02, Vol.72, p.S184-S184

2017

Volltextzugriff (PDF)

Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)

Annals of oncology, 2013-10, Vol.24 (10), p.2576-2581

2013

Volltextzugriff (PDF)

P3.01-039 Sequential Afatinib-Osimertinib Therapy in EGFR Mutation-Positive (EGFRm+) NSCLC: Analysis of Time on Treatment and OS

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2215-S2216

2017

Volltextzugriff (PDF)

Nature and nurture of tissue-specific macrophage phenotypes

Atherosclerosis, 2019-02, Vol.281, p.159-167

2019

Volltextzugriff (PDF)

First-line afatinib for advanced EGFR mutation-positive (EGFRm+) NSCLC: analysis of long-term responders in the Phase III LUX-Lung 3, 6 and 7 trials

European journal of cancer (1990), 2017-02, Vol.72, p.S176-S177

2017

Volltextzugriff (PDF)

A Single-Cell Transcriptome Atlas of the Human Pancreas

Cell systems, 2016-10, Vol.3 (4), p.385-394.e3

2016

Volltextzugriff (PDF)

Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis

Naunyn-Schmiedeberg's archives of pharmacology, 2024-05, Vol.397 (5), p.3477-3491

2024

Volltextzugriff (PDF)

Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database

Endoscopy, 2021-02, Vol.53 (2), p.166-170

2021

Volltextzugriff (PDF)

Modelling to inform the conservation and management of aquatic ecosystems: A synthesis of five case studies

Aquatic ecosystem health & management, 2023-07, Vol.26 (3), p.62-65

Koops, Marten A.

2023

Volltextzugriff (PDF)

420TiP UpSwinG: Real-world study of TKI activity in patients with EGFR mutation-positive (EGFRm+) NSCLC with uncommon mutations, and sequencing of afatinib followed by osimertinib

Annals of oncology, 2020-11, Vol.31, p.S1405-S1406

2020

Volltextzugriff (PDF)

Ex vivo expanded telomerase‐specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma

Clinical and experimental immunology, 2009-10, Vol.158 (1), p.125-132

2009

Volltextzugriff (PDF)

The consequences of null model selection for predicting mortality from multiple stressors

Proceedings of the Royal Society. B, Biological sciences, 2021-04, Vol.288 (1948), p.20203126-20203126

2021

Volltextzugriff (PDF)

Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements

European neuropsychopharmacology, 2015-11, Vol.25 (11), p.2062-2074

2015

Volltextzugriff (PDF)

Editorial: Transcriptional regulation of macrophage function

Frontiers in immunology, 2023, Vol.14, p.1321064-1321064

2023

Volltextzugriff (PDF)

Brain alterations in adult ADHD: Effects of gender, treatment and comorbid depression

European neuropsychopharmacology, 2014-03, Vol.24 (3), p.397-409

2014

Volltextzugriff (PDF)

A Meta-analysis on the Effectiveness of Offsetting Strategies to Address Harm to Freshwater Fishes

Environmental management (New York), 2022-11, Vol.70 (5), p.793-807

2022

Volltextzugriff (PDF)

Cashmeran as a potential endocrine disrupting chemical: What does the weight-of-the-evidence indicate?

Food and chemical toxicology, 2024-02, Vol.184, p.114351-114351, Article 114351

2024

Volltextzugriff (PDF)

1 – 25 von 18.314

Suche als RSS-Feed

Aktive Filter

SpracheAfrikaans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12.688)
Mit Volltextzugriff
(14.699)

Publikationsform

9 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(8.558)
Life Sciences & Biomedicine
(5.347)
Humans
(3.201)
Technology
(1.857)
Physical Sciences
(1.818)
Female
(1.755)
Male
(1.558)
Biological And Medical Sciences
(1.380)
Animals
(1.190)
Middle Aged
(1.093)
Medicin Och Hälsovetenskap
(1.035)
Chemistry
(954)
Aged
(924)
Adult
(920)
Computer Science
(890)
Social Sciences
(886)
Medical Sciences
(769)
Science & Technology - Other Topics
(727)
Biochemistry & Molecular Biology
(698)
Fundamental And Applied Biological Sciences. Psychology
(677)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(6.065)
EZB Electronic Journals Library
(5.596)
MEDLINE
(4.626)
Ebook Central Perpetual and DDA
(3.336)
Journals@Ovid Complete
(3.174)
eBooks on EBSCOhost
(3.075)
Elsevier ScienceDirect Journals Complete
(2.793)
IngentaConnect Journals
(2.146)
Wiley Online Library Journals Frontfile Complete
(2.110)
NUS Single-Journal Subscriptions
(2.006)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.584)
JSTOR
(1.526)
Wiley Online Library Full Collection 2018
(1.390)
2022 ECC(Springer)
(1.080)
De Gruyter eBooks
(779)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(717)
Oxford University Press Journals Current
(668)
IEEE/IET Electronic Library
(564)
Taylor & Francis Journals Auto-Holdings Collection
(534)
Taylor & Francis
(498)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials

Nanofatigue behaviour of single struts of cast A356.0 foam: cyclic deformation, nanoindent characteristics and sub-surface microstructure

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104

Afatinib followed by osimertinib in patients with EGFR mutation-positive advanced NSCLC: A real-world study (GioTag)

Oxidative Stress Leads to β-Cell Dysfunction Through Loss of β-Cell Identity

Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages

Intratumoural injection of the toll-like receptor-2 6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I II trial

Afatinib vs gefitinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: overall survival (OS) data from LUX-Lung 7 (LL7)

Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)

P3.01-039 Sequential Afatinib-Osimertinib Therapy in EGFR Mutation-Positive (EGFRm+) NSCLC: Analysis of Time on Treatment and OS

Nature and nurture of tissue-specific macrophage phenotypes

First-line afatinib for advanced EGFR mutation-positive (EGFRm+) NSCLC: analysis of long-term responders in the Phase III LUX-Lung 3, 6 and 7 trials

A Single-Cell Transcriptome Atlas of the Human Pancreas

Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis

Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database

Modelling to inform the conservation and management of aquatic ecosystems: A synthesis of five case studies

420TiP UpSwinG: Real-world study of TKI activity in patients with EGFR mutation-positive (EGFRm+) NSCLC with uncommon mutations, and sequencing of afatinib followed by osimertinib

Ex vivo expanded telomerase‐specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma

The consequences of null model selection for predicting mortality from multiple stressors

Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements

Editorial: Transcriptional regulation of macrophage function

Brain alterations in adult ADHD: Effects of gender, treatment and comorbid depression

A Meta-analysis on the Effectiveness of Offsetting Strategies to Address Harm to Freshwater Fishes

Cashmeran as a potential endocrine disrupting chemical: What does the weight-of-the-evidence indicate?

Aktive Filter

Suchergebnisse filtern